4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-22-000094
Chief R&D Officer returned 657 shares (to the company)
- Chief R&D Officer acquired 2,571 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Scopelianos Angelo · Chief R&D Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-18 | Grant or award : show line 1 in the form | +2,571 | 22,751 | D | ||
| 2022-07-19 | Returned to the company : show line 2 in the form | −657 | $8.40 | $5,519 | 25,094 | D |
Loading xslF345X03/wf-form4_165834747880252.xml…